Search filters

List of works by Geny Piro

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

scientific article published on 23 May 2013

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

scientific article published on 5 June 2014

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.

scientific article published on 7 June 2016

Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment

scientific article published on 15 October 2015

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.

scientific article published on September 2011

Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification

scientific article published on 02 September 2020

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy.

scientific article published on 30 April 2013

Molecular alterations in basal cell carcinoma subtypes

scientific article published on 24 June 2021

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around

scientific article published on 09 August 2019

Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance

scientific article published on 25 October 2018

Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer

scientific article published on 12 June 2020

Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation

scientific article published on 16 March 2018

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story

scientific article published on 10 October 2019

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

scientific article

Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.

scientific article

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase.

scientific article

Paulina is supported by:

About Paulina

Help